{"podcast":{"title":"Living Medicine","slug":"living-medicine-7074573","podcast_index_feed_id":7074573,"rss_url":"https://feeds.libsyn.com/547667/rss","website_url":"https://livingmedicineinstitute.com/","image_url":"https://static.libsyn.com/p/assets/e/8/0/6/e8066f1cec04486e16c3140a3186d450/Dr._Sandy_Newes_Artwork.png","author":"Dr. Sandy Newes","episode_count":51,"summary":"This is the Living Medicine podcast where we talk about ethical, medical use of psychedelic psychotherapy- teaching skills, examining the issues, and interviewing interesting people.","last_synced_at":"2026-06-04T16:21:01.168626+00:00","page_url":"https://stenobird.com/podcast/living-medicine-7074573"},"episode":{"title":"From Experience to Evidence: How Data-Driven Ketamine Treatment Is Combatting Depression","slug":"from-experience-to-evidence-how-data-driven-ketamine-treatment-is-combatting-depression","published_at":"2026-01-15T07:00:00+00:00","page_url":"https://stenobird.com/podcast/living-medicine-7074573/from-experience-to-evidence-how-data-driven-ketamine-treatment-is-combatting-depression","show_page_url":"https://stenobird.com/podcast/living-medicine-7074573","url":"https://485c1e09-45d8-4663-b442-542948ad8f19.libsyn.com/from-experience-to-evidence-how-data-driven-ketamine-treatment-is-combatting-depression","audio_url":"https://traffic.libsyn.com/secure/485c1e09-45d8-4663-b442-542948ad8f19/Living_Medicine_-_Nico_Grundmann.mp3?dest-id=4724072","summary":"Nicolas Grundmann is the Co-founder and CEO of Ember Health, which provides IV ketamine treatments for depression. As a board-certified emergency medicine physician, he launched Ember Health to create more effective, patient-centered treatment options. Nicolas is also a faculty member at the American Society of Ketamine Physicians, Psychotherapists and Practitioners, and is the Co-founder of Chenla Children's Healthcare, which improves pediatric care in Cambodia. In this episode… Mental health treatment is evolving as clinicians search for options that outperform traditional approaches. From data-driven care to treating trauma, anxiety, and depression together, how can clinicians create evidence-based ketamine treatments? According to emergency medicine physician Nicolas Grundmann, effective ketamine treatment starts with rigorous evidence, longitudinal data, and close care coordination. He emphasizes symptom-driven dosing, regular measurement using validated tools, and proactive follow-up to catch relapses early. Clinicians should also integrate outside therapists, help patients relearn emotional regulation after depression lifts, and avoid one-size-fits-all models. In this episode of Living Medicine , Dr. Sandy Newes talks with Nicolas Grundmann, Co-founder and CEO of Ember Health, about evidence-based ketamine treatment for depression. Nicolas talks about using real-world data to guide care, treating depression with comorbid PTSD and anxiety, and whether to include therapy during ketamine sessions.","meta_description":"Nicolas Grundmann is the Co-founder and CEO of Ember Health, which provides IV ketamine treatments for depression. As a board-certified emergency medicine…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3059,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/living-medicine-7074573/episodes/from-experience-to-evidence-how-data-driven-ketamine-treatment-is-combatting-depression/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/living-medicine-7074573/from-experience-to-evidence-how-data-driven-ketamine-treatment-is-combatting-depression.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}